Patent · US Active

Modified gherlin peptides

US8524871B2 · kind B2 · utility

2Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2011
Grant dateSep 3, 2013
Priority date
Expiry dateAug 17, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a peptide-type compound which induces secretion of growth hormone and which has the activity of increasing the intracellular calcium ion concentration, wherein at least one amino acid is replaced by a modified amino acid and/or a non-amino acid compound, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.